References
- SchwartzGFQuigleyHAAdherence and persistence with glaucoma therapySurv Ophthalmol200853Suppl 1S57S6819038625
- MansouriKIlievMERohrerKShaarawyTCompliance and knowledge about glaucoma in patients at tertiary glaucoma unitsInt Ophthalmol20113136937621986850
- FriedmanDSQuigleyHAGelbLUsing pharmacy claims data to study adherence to glaucoma medications: methodology and findings of the glaucoma and adherence and persistency study (GAPS)Invest Ophthalmol Vis Sci2007485052505717962457
- QuekDTOngGTPereraSALamoureuxELAungTPersistence of patients receiving topical glaucoma monotherapy in an Asian populationArch Ophthalmol201112964364821220621
- FiscellaRGLeeJDavisEJWaltJCost of illness of glaucoma: a critical and systematic reviewPharmacoeconomics20092718919819354339
- RivaIKatsanosAFlorianiILong-term 24-hour intraocular pressure control with travoprost monotherapy in patients with primary open-angle glaucomaJ Glaucoma201423853554024786103
- QuarantaLRivaIKatsanosAFlorianiICentofantiMKonstasAGSafety and efficacy of travoprost solution for the treatment of elevated intraocular pressureClin Ophthalmol2015963364325914522
- DenisPCovertDRealiniATravoprost in the management of open-angle glaucoma and ocular hypertensionClin Ophthalmol20071112419668462
- AndersonDRPatellaVMAutomated Static Perimetry2nd ed363St Louis, MOMosby1999
- HonrubiaFGarcía-SánchezJPoloVde la CasaJMSotoJConjunctival hyperaemia with the use of latanoprost versus other prostaglandin analogs in patients with ocular hypertension or glaucoma: a meta-analysis of randomized clinical trialsBr J Ophthalmol20099331632119019922
- KassMAHeuerDKHigginbothamEJThe ocular hypertension treatment study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucomaArch Ophthalmol200212070171312049574